Association between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients

dc.contributor.authorRodríguez-Molinero, Alejandro
dc.contributor.authorGálvez-Barrón, César
dc.contributor.authorMiñarro Alonso, Antonio
dc.contributor.authorMacho, Oscar
dc.contributor.authorLópez, Gabriela F.
dc.contributor.authorRobles, Maria Teresa
dc.contributor.authorDapena, María Dolores
dc.contributor.authorMartínez, Sergi
dc.contributor.authorMilà Ràfols, Núria
dc.contributor.authorMonaco, Ernesto E.
dc.contributor.authorHidalgo García, Antonio
dc.date.accessioned2020-11-18T13:11:11Z
dc.date.available2020-11-18T13:11:11Z
dc.date.issued2020-10-15
dc.date.updated2020-11-18T13:11:11Z
dc.description.abstractmportance The rapid pandemic expansion of the disease caused by the new SARS-CoV-2 virus has compromised health systems worldwide. Knowledge of prognostic factors in affected patients can help optimize care. Objective The objective of this study was to analyze the relationship between the prognosis of COVID-19 and the form of presentation of the disease, the previous pathologies of patients and their chronic treatments. Design, participants and locations This was an observational study on a cohort of 418 patients admitted to three regional hospitals in Catalonia (Spain). As primary outcomes, severe disease (need for oxygen therapy via nonrebreather mask or mechanical ventilation) and death were studied. Multivariate binary logistic regression models were performed to study the association between the different factors and the results. Results Advanced age, male sex and obesity were independent markers of poor prognosis. The most frequent presenting symptom was fever, while dyspnea was associated with severe disease and the presence of cough with greater survival. Low oxygen saturation in the emergency room, elevated CRP in the emergency room and initial radiological involvement were all related to worse prognosis. The presence of eosinophilia (% of eosinophils) was an independent marker of less severe disease. Conclusions This study identified the most robust markers of poor prognosis for COVID-19. These results can help to correctly stratify patients at the beginning of hospitalization based on the risk of developing severe disease.
dc.format.extent13 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec704650
dc.identifier.issn1932-6203
dc.identifier.pmid33057443
dc.identifier.urihttps://hdl.handle.net/2445/172193
dc.language.isoeng
dc.publisherPublic Library of Science (PLoS)
dc.relation.isformatofReproducció del document publicat a: https://doi.org/10.1371/journal.pone.0239571
dc.relation.ispartofPLoS One, 2020, vol. 15, num. 10, p. e0239571
dc.relation.urihttps://doi.org/10.1371/journal.pone.0239571
dc.rightscc-by (c) Rodríguez-Molinero, Alejandro et al., 2020
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttp://creativecommons.org/licenses/by/3.0/es
dc.sourceArticles publicats en revistes (Genètica, Microbiologia i Estadística)
dc.subject.classificationCOVID-19
dc.subject.classificationTerapèutica
dc.subject.otherCOVID-19
dc.subject.otherTherapeutics
dc.titleAssociation between COVID-19 prognosis and disease presentation, comorbidities and chronic treatment of hospitalized patients
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
704650.pdf
Mida:
477.83 KB
Format:
Adobe Portable Document Format